We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Follow-Up Report on Hand Transplantation

By HospiMedica staff writers
Posted on 06 Sep 2000
A follow-up on a transplant performed in January 1999 has shown that early success in hand transplantation can be achieved with the use of current immunosuppressive drugs. More...
The operation, the first hand transplant to be performed in the United States, took place at the Jewish Hospital of Louisville (KY, USA), following a successful hand transplant performed in France only four months earlier. A report and update on the U.S. transplant was published in The New England Journal of Medicine (2000;343:468-473).

The team of doctors who performed the operation report that the patient's skin, wound, and bone healing were normal following the operation, and nerve regeneration more rapid than expected. However, the patient experienced three episodes of acute cellular rejection, at six, 20, and 27 weeks. These were successfully treated with intravenous methylprednisolone, topical tacrolimus, and clobetasol, a protocol relying mainly on the team's studies of rejection treatment in pigs.

Less than four months after the transplantation, the patient returned to work. At one year, pain, pressure, and temperature had developed in the patient's hand and fingers. By then, the patient was able to perform many functions with his new hand that had been impossible with his prosthesis. These included tying his shoelaces and throwing a baseball. The doctors report that the patient is psychologically well adjusted and has incorporated the graft into his self-image.

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Syringes
Prefilled Saline Flush Syringes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.